Spinola et al., 1993 - Google Patents
The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteinsSpinola et al., 1993
View PDF- Document ID
- 4409139868355677741
- Author
- Spinola S
- Griffiths G
- Shanks K
- Blake M
- Publication year
- Publication venue
- Infection and immunity
External Links
Snippet
Haemophilus ducreyi contains a major outer membrane protein (MOMP) whose apparent molecular weight is 39,000 to 42,000 for all strains tested. Two monoclonal antibodies (MAbs), designated 9D12 and 2C7, bound to the MOMP for all strains of H. ducreyi tested …
- 101710019345 MT2024.1 0 title abstract description 86
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
- C07K14/245—Escherichia (G)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Spinola et al. | The major outer membrane protein of Haemophilus ducreyi is a member of the OmpA family of proteins | |
Exner et al. | Isolation and characterization of a family of porin proteins from Helicobacter pylori | |
Munson et al. | Purification and comparison of outer membrane protein P2 from Haemophilus influenzae type b isolates. | |
Fenno et al. | Sequence analysis, expression, and binding activity of recombinant major outer sheath protein (Msp) of Treponema denticola | |
US20030228328A1 (en) | Vaccine for periodontal disease | |
US20080241151A1 (en) | Virulence genes, proteins, and their use | |
AU594400B2 (en) | Major iron-regulated protein of neisseria gonorrhoeae and its use as vaccine | |
Stephens et al. | Pili of Neisseria meningitidis. Analysis of structure and investigation of structural and antigenic relationships to gonococcal pili. | |
EP0432203A1 (en) | Legionellosis vaccines and methods for their production | |
KR100331358B1 (en) | Rib protein, a cell surface protein that provides immunity against many strains of Group B Streptococcus, methods of purification of the protein, reagent kits, and pharmaceutical compositions | |
LaFrentz et al. | Proteomic analysis of Flavobacterium psychrophilum cultured in vivo and in iron-limited media | |
Anwar et al. | Antibody response to acute Pseudomonas aeruginosa infection in a burn wound | |
Ayalew et al. | Mannheimia haemolytica chimeric protein vaccine composed of the major surface-exposed epitope of outer membrane lipoprotein PlpE and the neutralizing epitope of leukotoxin | |
Lo et al. | Characterization of two lipoproteins in Pasteurella multocida | |
US6015889A (en) | Protein rib, a cell surface protein that confers immunity to many strains of the group B streptococcus: process for purification of the protein, reagent kit and pharmaceutical composition | |
EP0550683B1 (en) | Vaccine suitable for combatting bordetella pertussis | |
Newton et al. | Isolation and characterization of flagella from Edwardsiella ictaluri | |
Srikumar et al. | Immunological properties of recombinant porin of Haemophilus influenzae type b expressed in Bacillus subtilis | |
US5300632A (en) | Method for purifying an outer membrane protein of Haemophilus influenzae | |
MXPA00010026A (en) | Transferrin receptor genes of moraxella. | |
Gilsdorf | Role of pili in Haemophilus influenzae adherence, colonization and disease | |
AU681130C (en) | Protein rib, a cell surface protein that confers immunity tomany strains of the group B streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition | |
EP1977761A2 (en) | Pharmaceutical compositions containing protein nma0939 | |
EP1693378B1 (en) | Protein nmb1125 and use thereof in pharmaceutical formulations | |
Hassan-King et al. | SDS-PAGE analysis of membrane proteins of group A Neisseria meningitidis isolated before and during an epidemic of group A meningococcal disease in northern Nigeria |